Thyrocare Technologies has officially announced the cancellation of its scheduled earnings conference call, which was intended to discuss the audited financial results for the quarter and financial year ended March 31, 2026. The event, originally set for May 07, 2026, was called off due to unforeseen circumstances. The company has confirmed that a revised schedule for the investor and analyst discussion will be provided at a later date.
Conference Call Cancellation Update
Thyrocare Technologies has notified the stock exchanges regarding the cancellation of its upcoming investor interaction. The conference call, which was meant to provide a detailed overview of the company’s financial performance for the period ending March 31, 2026, will not take place on the originally scheduled date of Thursday, May 07, 2026.
Next Steps for Investors
Management stated that the decision to cancel the call was prompted by unforeseen circumstances. While the immediate session is deferred, Thyrocare Technologies intends to reschedule the discussion to ensure analysts and stakeholders are briefed on the audited financial results. Shareholders and interested parties are advised to wait for further updates, as the company will communicate the revised schedule in due course.
Source: BSE
